GlassScriptPhysician profile
Stephen M Schroeder
NPI 1083658926
$27,596.92
in general payments reported to CMS, 2019-2025
19 companies · $1,650 in 2025
The $1,650 reported for 2025 was more than what 88% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $1,480 · 2021: $3,206 · 2022: $301 · 2023: $3,744 · 2024: $2,229 · 2025: $1,650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,618 · Travel and Lodging: $2,955 · Consulting Fee: $1,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,618.05 |
| Travel and Lodging | $2,955.39 |
| Consulting Fee | $1,050.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $12,564.74 | 2019-2024 | Knee & Hip Implants Suspensory Fixation Acl Tightrope |
| Acumed LLC | $5,967.90 | 2019-2023 | Acumed |
| Steelhead Surgical INC | $2,941.62 | 2019-2024 | |
| Exactech, INC. | $2,308.84 | 2019-2025 | |
| Paragon 28, INC. | $1,301.87 | 2021-2023 | Apex 3d |
| Stryker Corporation | $1,085.38 | 2019-2022 | |
| Gramercy Extremity Orthopedics LLC | $484.37 | 2021-2023 | |
| Encore Medical, LP | $253.02 | 2021 | |
| Medshape, INC. | $140.40 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $121.88 | 2024 | Exparel |
| Crossroads Extremity Systems, LLC | $91.00 | 2019 | |
| Integra Lifesciences Corporation | $80.00 | 2019 | |
| Trimed, INC. | $73.08 | 2020 | |
| Zimmer Biomet Holdings, INC. | $68.00 | 2020-2021 | |
| Fidia Pharma USA INC. | $48.72 | 2024 | Triluron |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $19.47 | 2025 | Exogen Ultrasound Bone Healing System |
| Vertex Pharmaceuticals Incorporated | $17.52 | 2025 | |
| Avanos Medical | $15.77 | 2019 | |
| Merck Sharp & Dohme LLC | $13.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$990,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Schroeder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.